Cipla is currently trading at Rs. 1524.60, up by 3.40 points or 0.22% from its previous closing of Rs. 1521.20 on the BSE.

The scrip opened at Rs. 1523.35 and has touched a high and low of Rs. 1527.00 and Rs. 1513.75 respectively. So far 16662 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1672.20 on 23-Oct-2025 and a 52 week low of Rs. 1310.05 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 1536.20 and Rs. 1495.95 respectively. The current market cap of the company is Rs. 123294.16 crore.

The promoters holding in the company stood at 29.21%, while Institutions and Non-Institutions held 54.79% and 16.00% respectively.

Cipla has completed acquisition of 100% stake in Inzpera Healthsciences (Inzpera) on December 04, 2025. Accordingly, Inzpera has now become a wholly owned subsidiary of the Company.

The acquisition is a strategic move aimed at combining Inzpera’s extensive portfolio of paediatric pharmaceutical and wellness products with the company’s strong distribution network and operational capabilities to drive growth and scalability. Earlier, the company had entered into definitive agreements to acquire 100% stake in Inzpera Healthsciences.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.